Alami NH, Smith RB, Carrasco MA, et al. Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 2014;81(3):536-543. doi:10.1016/j.neuron.2013.12.018
Haidet-Phillips AM, Roybon L, Gross SK, et al. Gene profiling of human induced pluripotent stem cell-derived astrocyte progenitors following spinal cord engraftment. Stem Cells Transl Med. 2014;3(5):575-85. doi:10.5966/sctm.2013-0153
Schwarz-Romond T, Kiskinis E, Eggan K. Focus on induced pluripotency and cellular reprogramming. EMBO J. 2015;34(11):1435. doi:10.15252/embj.201591615
Sances S, Bruijn LI, Chandran S, et al. Modeling ALS with motor neurons derived from human induced pluripotent stem cells. Nat Neurosci. 2016;19(4):542-53. doi:10.1038/nn.4273
Andrews PW, Ben-David U, Benvenisty N, et al. Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications. Stem Cell Reports. 2017;9(1):1-4. doi:10.1016/j.stemcr.2017.05.029
Fatkin D, Santiago CF, Huttner IG, Lubitz SA, Ellinor PT. Genetics of Atrial Fibrillation: State of the Art in 2017. Heart Lung Circ. 2017;26(9):894-901. doi:10.1016/j.hlc.2017.04.008
Mezger A, Nilsson M, Andersson DI. Rapid Antibiotic Susceptibility Testing for Urinary Tract Infections. Methods Mol Biol. 2017;1616:147-153. doi:10.1007/978-1-4939-7037-7_9
Mercader JM, Liao RG, Bell AD, et al. A Loss-of-Function Splice Acceptor Variant in Is Protective for Type 2 Diabetes. Diabetes. 2017;66(11):2903-2914. doi:10.2337/db17-0187
Quadrato G, Brown J, Arlotta P. The promises and challenges of human brain organoids as models of neuropsychiatric disease. Nat Med. 2016;22(11):1220-1228. doi:10.1038/nm.4214
Ofengeim D, Mazzitelli S, Ito Y, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease. Proc Natl Acad Sci U S A. 2017;114(41):E8788-E8797. doi:10.1073/pnas.1714175114